Tanaka Capital Management’s Gilead Sciences GILD Stock Holding History

Tanaka Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-31,749	Closed	-$2.65M	–	54
2016 Q2	$2.65M	Buy	31,749 +5,575	+21%	+$495K	6.81%	4
2016 Q1	$2.4M	Sell	26,174 -802	-3%	-$72.3K	5.41%	5
2015 Q4	$2.73M	Sell	26,976 -6,667	-20%	-$694K	5.88%	3
2015 Q3	$3.3M	Buy	33,643 +1,090	+3%	+$121K	8.35%	4
2015 Q2	$3.81M	Buy	32,553 +2,100	+7%	+$229K	9.45%	3
2015 Q1	$2.99M	Sell	30,453 -2,314	-7%	-$235K	8.26%	4
2014 Q4	$3.09M	Buy	32,767 +6,789	+26%	+$702K	9.19%	3
2014 Q3	$2.81M	Buy	25,978 +19,083	+277%	+$1.87M	8.21%	4
2014 Q2	$572K	Buy	+6,895	New	+$537K	1.51%	21

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tanaka Capital Management's GILD Position: Q3 2016 in Review

Tanaka Capital Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 31,749 shares — an estimated $2.65M sold.

Tanaka Capital Management first reported a position in GILD in Q2 2014 and held it in 9 quarters. The position peaked at $3.81M in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Tanaka Capital Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Tanaka Capital Management sold 31,749 Gilead Sciences shares in Q3 2016, an estimated $2.65M.
Tanaka Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 9 quarters.
Tanaka Capital Management's Gilead Sciences position peaked at $3.81M in Q2 2015.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Tanaka Capital Management's 13F filing for Q3 2016, filed 15 Nov 2016.